| Old Articles: <Older 18121-18130 Newer> |
 |
The Motley Fool November 6, 2006 Brian Lawler |
Neurocrine's Big Headache Another clinical trial means a steep drop in share price, but the biopharmaceutical's not dead yet. Investors, take note.  |
The Motley Fool November 6, 2006 Ryan Fuhrmann |
Kenneth Cole: Fashion That Pays The apparel and footwear company lacks consistent growth, but pays a decent dividend.  |
The Motley Fool November 6, 2006 Steven Mallas |
THQ's Saintly Quarter An options inquiry notwithstanding, the game maker is looking solid and blowing away estimates. Investors, take note.  |
The Motley Fool November 6, 2006 Cope & Rush |
Healthy Business, Healthy Planet Co-Op America aims to harmonize the corporate world with a greener world. To that end, the non-profit goes so far as to help investors make green choices for their portfolios.  |
The Motley Fool November 6, 2006 |
Cabela's Cashes In: Fool by Numbers The outdoor sports retailer released third-quarter earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...  |
The Motley Fool November 6, 2006 |
Merger Ahead for Smith & Nephew?: Fool by Numbers The medical technology company released third-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...  |
The Motley Fool November 6, 2006 Brian Lawler |
The Impending Verdict on Momenta The drug developer isn't willing to wait for potential legislation on generic drugs. Investors, take note.  |
The Motley Fool November 6, 2006 |
PDL Biopharma Packs a Punch: Fool by Numbers The pharmaceutical released third-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...  |
The Motley Fool November 6, 2006 Tom Taulli |
Oracle Finally Buys Stellent Oracle's enterprise content management software was fairly weak, so it bought out a top player in that space. Investors, take note.  |
The Motley Fool November 6, 2006 Ryan Fuhrmann |
Steve Madden Surfs the Fashion Wave The footwear marketer and retailer reported another impressive quarter, but does recently reduced guidance suggest the tide is turning? Investors, take note.  |
| <Older 18121-18130 Newer> Return to current articles. |